Automated sequence screening of the entire dystrophin cDNA in Duchenne dystrophy: Point mutation detection

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 141 B, Issue 1, 2006, Pages 44-50

  Hamed, Sherifa Ahmed ^a,b,c   Hoffman, Eric P ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b Saudi German Hospital   (Saudi Arabia)

^c NONE   (Saudi Arabia)

Author keywords

Automated sequencing; Duchenne muscular dystrophy; Point mutation; Quantitative multiplex polymerase chain reaction

Indexed keywords

COMPLEMENTARY DNA; DYSTROPHIN;

ARTICLE; AUTOMATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; HUMAN TISSUE; INTRON; MUSCLE BIOPSY; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; STOP CODON;

EID: 30344482510     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30234     Document Type: Article

References (52)

1. Ahn AH, Kunkel LM. 1993. The structural and functional diversity of dystrophin. Nat Genet 3:283-291.
2. Armour JA, Sismani C, Patsalis PC, Cross G. 2000. Measurement of locus copy number by hybridisation with amplifiable probes. Nucleic Acids Res 28:605-609.
3. Bakker E, Van Broeckhoven C, Bonten EJ, Van De Vooren MJ, Veenema H, Van Hul W, van Ommen GJB, Vandenberghe A, Pearson PL. 1987. Germline mosaicism and Duchenne muscular dystrophy mutations. Nature 329:554-556.
4. Barton-Davis ER, Cordier L, Shoturma DI, Leland SE, Sweeney HL. 1999. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 104:375-381.
5. Baserga SJ, Benz EJ. 1988. Nonsense mutations in the human β-globulin gene affect mRNA metabolism. Proc Natl Acad Sci USA 85:2056-2060.
6. Beggs AH, Koenig M, Boyce FM, Kunkel LM. 1990. Detection of 98% of DMD/ BMD gene deletions by polymerase chain reaction. Hum Genet 86: 45-48.
7. Chamberlain JS, Gibbs RA, Raier JE, Nguyen PN, Caskey CT. 1988. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic acid Res 16:11141-11156.
8. Chelly J, Gilgenkrantz H, Lambert M, Hamard G, Chafey P, Recan D, Katz P, de la Chapelle A, Koenig M, Ginjaar B, Fardeau M, Tome F, Khan A, Kaplan JC. 1991. Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophy. Cell 63: 1239-1248.
9. Cohen AS, Najarian DR, Karger BL. 1990. Separation and analysis of DNA sequence reaction products by capillary gel electrophoresis. J Chromatogr 516:46-60.
10. Cooper DN, Krawczak M. 1990. The mutational spectrum of single base pair substitutions causing human genetic disease: Patterns and predictions. Hum Genet 85:55-74.
11. Cooper DN, Krawczak M. 1993. Human gene mutation. Oxford: Bios Scientific.
12. Culterson MR. 1999. RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends Genet 15: 74-80.
13. den Dunnen JT, Grootscholten PM, Bakker E, Blonden LA, Ginjaar HB, Wapenaar MC, van Paassen HM, van Broeckhoven C, Pearson PL, van Ommen GJ. 1989. Topography of the Duchenne muscular dystrophy. DMD gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 45:835-847.
14. Galvagni F, Saad FA, Danieli GA, Miorin M, Vitiello L, Mostacciolo ML, Angilini C. 1994. A study on duplications of the dystrophin gene: Evidence of a geographical difference in the distribution of breakpoints by intron. Hum Genet 94:83-87.
15. Gardner RJ, Bobrow M, Roberts RG. 1995. The identification of point mutations in Duchenne muscular dystrophy patients using reverse transcript PCR and the protein truncation test. Am J Hum Genet 57: 311-320.
16. Hamed SA, Sutherland-Smith AJ, Gorospe JRM, Kendrick-Jones J, Hoffman EP. 2005. DNA sequence analysis for structure/function and mutation studies in Becker muscular dystrophy. Clin Genet 68:69-79.
17. Hentze MW, Kulozik AE. 1999. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96:307-310.
18. Hoffman EP. 1993. Genotype/phenotype correlations in Duchenne/Becker muscular dystrophy. In: Partridge TA, editor. Molecular and cell biology of muscular dystrophy. London: Chapman and Hall, Inc. pp 12-36.
19. Hoffman EP. 1997. The muscular dystrophies. In: Rosenberg RN, Prusiner SB, DiMauro Barchi S, editors. The molecular and genetic basis of neurological diseases. Newton, Massachusetts: Butterworth-Heinmann.
20. Hoffman EP, Brown RH, Kunkel LM. 1987. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51:919-928.
21. Hoffman EP, Morgan JE, Watkins SC, Partridge TA. 1990. Somatic/reversion suppression of the mouse mdx phenotype in vivo. J Neurol Sci 99:9-25.
22. Hu X, Ray PN, Murphy EG, Thompson MW, Worton RG. 1990. Duplication of Duchenne muscular dystrophy locus: It frequency, distribution, origin, and phenotype/genotype correlation. Am J Hum Genet 46: 682-695.
23. Huang XG, Quesada MA, Mathies RA. 1992. DNA sequencing using capillary array electrophoresis. Anal Chem 64:2149-2154.
24. Humphires B, Ley T, Anagnou N, Baur A, Nienhuis A. 1994. β-39 thalassemia gene: A premature termination codon causes β-RNA deficiency without affecting cytoplasmic β-RNA stability. Blood 64: 23-32.
25. Kekou K, Mavrou A, Florentin L, Youroukos S, Zafiriou DI, Skouteli HN, Metaxotou C. 1999. Screening of minor changes in the distal part of the human dystrophin gene in Greek DMD/BMD patients. Eur J Hum Genet 7:179-187.
26. Klein CJ, Coovert DD, Bulman DE, Ray PN, Mendelll JR, Burghes AH. 1992. Somatic reversion/suppression in Duchenne muscular dystrophy. DMD: Evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet 50:950-959.
27. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkle LM. 1987. Complete cloning of Duchenne muscular dystrophy. DMD, cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509-517.
28. Kunkel TA, Soni A. 1988. Mutagenesis by transient misalignment. J Biol Chem 263:14784-14789.
29. Leiden Database for DMD/BMD. 2005. http://www.dmd.nl/
30. Lenk U, Hanke R, Thiele H, Speer A. 1993. Point mutations at the carboxy terminus of the human dystrophin gene: Implications for an association with mental retardation in DMD patients. Hum Mol Genet 2:877-1881.
31. Ljunggren A, Duggan DJ, McNally E, Boylan KB, Gama CH, Kunkle LM, Hoffman EP. 1995. Primary adhalin deficiency as a cause of muscular dystrophy in patients with normal dystrophin. Ann Neurol 38:367-372.
32. Monaco AP, Nerve RL, Colletti-Feener CA, Bertelson CJ, Kurnit DM, Kunkel LM. 1988. Isolation of candidate cDNAs for portions of Duchenne muscular dystrophy gene. Nature 323:646-650.
33. Nicholson LVB, Johnson MA, Bushby KMD, Gardner-Medwin D. 1993. Functional significance of dystrophin positive fibers in DMD. Arch Dis Child 68:632-636.
34. Oudet C, Hanauer A, Clemens P, Caskey T, Mendell JR. 1992. Two hot spots of recombination in the DMD gene correlate with the deletion prone regions. Hum Mol Genet 1:599-603.
35. Pegoraro E, Schimke RN, Garcia C, Stern H, Cadaldini M, Angilini C, Barbosa E, Carroll J, Marks WA, Neville HE, Hoffman EP. 1995. Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: Evidence of failure of dystrophin production in dystrophin component myonuclei. Neurology 45:677-690.
36. Prior TW, Bartolo C, Pearl DK, Papp AC, Snyder PJ, Sedra MS, Burghes AH, Mendell JR. 1995. Spectrum of small mutations in the dystrophin coding region. Am J Hum Genet 57:22-33.
37. Roberts RG, Bobrow M, Bentley DR. 1992. Point mutations in the dystrophin gene. Proc Natl Acad Sci USA 89:2331-2335.
38. Roest PAM, Robers RG, Sugino S, van Ommen GJB, den Dunnen JT. 1993. Protein truncation test. PTT, for rapid detection of translation-terminating mutations. Hum Mol Genet 2:1719-1721.
39. Saad FA, Vita G, Mora M, Morandi L, Vitiello L, Oliviello S, Danieli GA. 1993. A novel nonsense mutation in the human dystrophin gene. Hum Mutat 2:314-316.
40. Saito K, Ikeya K, Kondo E, Yamauchi A, Sukama I, Komine S, Harada T, Mishima M, Komine M, Osawa M, Fukuyama Y. 1995. Somatic mosaicism for a DMD gene deletion. Am J Hum Genet 56:806-812.
41. Takeshita K, Forget B, Scarpa A, Benz E. 1984. intranuclear defect of β-globulin mRNA accumulation due to premature translation termination codon. Blood 64:13-22.
42. Tubiello G, Carrera P, Soriani N, Morandi L, Ferrari M. 1995. Mutational analysis of muscle and brain specific promoter region of dystrophin in DMD/BMD Italian patients by denaturing gradient gel electrophoresis (DGGE). Molecular Cell Probes 9:441-446.
43. Tuffery-Giraud S, Chambert S, Demaille J, Claustres M. 1999. Point mutations in the dystrophin gene: Evidence for frequent use of cryptic splice sites as a result of splicing defects. Hum Mutat 14:359-368.
44. van Deutekom JC, Bremmer-Bout M, Janson AAM, Ginjaar HB, Baas F, den Dunnen JT, van Ommen GJB. 2001. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum Mol Genet 10:1547-1554.
45. Verbovaia LV, Razin SV. 1997. Mapping of replication origins and termination sites in Duchenne muscular dystrophy gene. Genomics 45: 24-30.
46. Wagner KR, Hamed S, Hadley DW, Gropman AL, Burstein AH, Escolar DM, Hoffman EP, Fischbeck KH. 2001. Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutation. Ann Neurol 49:706-711.
47. Wapenaar MC, Kievits T, Hart KA, Abbs S, Blonden LA, den Dunnen JT, Groostscholten PM, Bakker E, Verellen-Dumoulin C, Bobrow M, van Ommen GJB, Pearson PL. 1988. A deletion hot spot in the Duchenne muscular dystrophy gene. Genomics 22:102-108.
48. White S, Kalf M, Liu Q, Villerius M, Engelsma D, Kriek M, Vollebregt E, Bakker B, van Ommen GB, Breuning MH, den Dunnen JT. 2002. Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization. Am J Hum Genet 71:365-374.
49. Whittock NV, Roberts RG, Mathew CG, Abbs SJ. 1997. Dystrophin point mutation screening using a multiplexed protein truncation test. Genet Test 1:115-123.
50. Wood S, McGillivray BC. 1988. Germinal mosaicism in Duchenne muscular dystrophy. Hum Genet 78:282-284.
51. Worton RG, Thompson MW. 1988. Genetics of Duchenne muscular dystrophy. Annu Rev Genet 22:601-629.
52. Zhou JH, Hoffman EP. 1994. Pathophysiology of sodium channelopathies: Studies of sodium channel expression by quantitative multiplex fluorescence polymerase chain reaction. J Biol Chem 269:18563-18571.